Skip to main content
OpenTrials
Completed

NCT Number: NCT01447875

The Effects of Sedative on the Fluid Responsiveness in Critically Ill Patients

Hypotension and bradycardia are often observed following induction of dexmedetomidine or propofol sedation.Cardiac preload decrease by sedative agents was often considered as one of main causes for this hypotension.The investigators hypothesized that hypotension after induction of sedation is caused by decrease of preload by sedative agents,and passive leg raising (PLR)test could predict this event.Dexmedetomidine or propofol infusion in patients with circulatory failure decrease cardiac preload and enhance preload-dependency and fluid responsiveness.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 1

Primary location

Nanjing Zhong-Da Hospital, Southeast University School of Medicine

Nanjing, 210009, China

About this study

In this clinical trial,the investigators hypothesized dexmedetomidine or propofol infusion in patients with circulatory failure decrease cardiac preload and enhanced preload-dependency and fluid responsiveness,and PLR induced pulse pressure variation (PLR-ΔPP) could predict the hypotension during dexmedetomidine induction in critically ill patients.Before dexmedetomidine or propofol infusion, the investigators will conduct passive leg raising test. At first, the patient's trunk was elevated 45 degrees for the first set of measurements. Then, the lower limbs were raised to a 45° angle while the patient's trunk was lowered to a supine position to measure peak BP (usually within 30-90 s). Hemodynamic profiles planned to be measured are SBP, DBP, CVP and HR.Sedation was induced with a dexmedetomidine 0.5μg/kg over 10 min loading, followed by a maintenance infusion of 0.2-0.7 μg/kg/h for one hour. The dose of propofol was titrated targeting the Richmond agitation sedation scale (RASS) ranged from -2 to -1 (bispectral index: 60-75).Hypotension was defined as a SBP less than 80 mmHg or DBP was less than 50 mmHg, or greater than 30% decrease from baseline for longer than 60 s. Bradycardia was defined a HR 50 /min or greater than 30% change from baseline for longer than 60 s. Receiver operator characteristic curve analysis was performed to evaluate sensitivity and specificity of the value PLR-ΔPP to detect patients at high risk of hypotension.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients with at least one of the clinical manifestations of acute circulatory failure; patients undergoing dexmedetomidine or propofol infusion

Exclusion criteria

  • deep venous thrombosis or elastic compression stocking
  • an increase in the intra-abdominal pressure confirmed by clinical examination
  • serious central nervous system pathology (head trauma, severe dementia, acute stroke, uncontrolled seizures)
  • severe liver disease(Child-Pugh class C)
  • unstable angina or acute myocardial infarction
  • left ventricular ejection fraction less than 30%
  • heart rate(HR) less than 50/min, heart block with second- or third degree
  • systolic blood pressure (SBP) less than 90 mmHg despite 2 vasopressors infusion continuously before the begin of dexmedetomidine infusion

Treatment and study plan

Passive Leg Raising

Other

elevation of both legs to a 45 degrees for about 1-2 minute before sedation

Other names: Passive Leg Raising testing

propofol or mexmedetomidine

Drug

Primary outcomes

  1. the area under ROC curve to predict hypotension

    Time frame: 60 min around passive leg raising test

    area under ROC curve of blood pressure changes during PLR to predict hypotension during sedation

Sponsors and collaborators

Lead sponsor

Southeast University, China

Other

Registry information

Official study title

The Effects of Propofol and Dexmedetomidine Infusion on the Fluid Responsiveness in Critically Ill Patients

Important dates

Study start
2011
Primary completion
2013
Study completion
2013
First posted
Oct 6, 2011
Registry last updated
Jan 29, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.